Skip to main content
Figure 1 | Critical Care

Figure 1

From: Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey

Figure 1

Changes in antithrombin (AT) activity. The median baseline AT activity was less than 40% in both groups. AT activities increased to the normal range (>80%) in AT3000 group, but this level was not recovered in the AT1500 group throughout 7 days. AT1500: 1,500 IU/day of AT substitution for 3 days; AT3000: 3,000 IU/day of AT substitution for 3 days. The central horizontal bars, columns, and peripheral horizontal bars indicate the median values, the 25th to 75th percentiles, and the 10th to 90th percentiles, respectively. *P <0.001 versus AT1500 at each day. #P <0.001 versus AT activity of each group at day 2, 4, or 7.

Back to article page

Critical Care

ISSN: 1364-8535